OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 evolution in an immunocompromised host reveals shared neutralization escape mechanisms
Sarah A. Clark, Lars E. Clark, Junhua Pan, et al.
Cell (2021) Vol. 184, Iss. 10, pp. 2605-2617.e18
Open Access | Times Cited: 177

Showing 1-25 of 177 citing articles:

SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses
Wanwisa Dejnirattisai, Jiandong Huo, Daming Zhou, et al.
Cell (2022) Vol. 185, Iss. 3, pp. 467-484.e15
Open Access | Times Cited: 921

The evolution of SARS-CoV-2
Peter V. Markov, Mahan Ghafari, Martin Beer, et al.
Nature Reviews Microbiology (2023) Vol. 21, Iss. 6, pp. 361-379
Open Access | Times Cited: 724

Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum
Aekkachai Tuekprakhon, Rungtiwa Nutalai, Aiste Dijokaite-Guraliuc, et al.
Cell (2022) Vol. 185, Iss. 14, pp. 2422-2433.e13
Open Access | Times Cited: 668

Receptor binding and complex structures of human ACE2 to spike RBD from omicron and delta SARS-CoV-2
Pengcheng Han, Linjie Li, Sheng Liu, et al.
Cell (2022) Vol. 185, Iss. 4, pp. 630-640.e10
Open Access | Times Cited: 449

Structural and functional characterizations of infectivity and immune evasion of SARS-CoV-2 Omicron
Zhen Cui, Pan Liu, Nan Wang, et al.
Cell (2022) Vol. 185, Iss. 5, pp. 860-871.e13
Open Access | Times Cited: 379

Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant by Sera From BNT162b2 or CoronaVac Vaccine Recipients
Lu Lu, Bobo Wing-Yee Mok, Lin Lei Chen, et al.
Clinical Infectious Diseases (2021) Vol. 75, Iss. 1, pp. e822-e826
Open Access | Times Cited: 373

Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants
Meng Yuan, Deli Huang, Chang‐Chun D. Lee, et al.
Science (2021) Vol. 373, Iss. 6556, pp. 818-823
Open Access | Times Cited: 362

De novo emergence of a remdesivir resistance mutation during treatment of persistent SARS-CoV-2 infection in an immunocompromised patient: a case report
Shiv Gandhi, Jon Klein, Alexander J. Robertson, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 238

Monoclonal antibodies for COVID-19 therapy and SARS-CoV-2 detection
Yu‐Chyi Hwang, Ruei‐Min Lu, Shih-Chieh Su, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 194

SARS-CoV-2 prolonged infection during advanced HIV disease evolves extensive immune escape
Sandile Cele, Farina Karim, Gila Lustig, et al.
Cell Host & Microbe (2022) Vol. 30, Iss. 2, pp. 154-162.e5
Open Access | Times Cited: 193

Tracking SARS-CoV-2 Omicron diverse spike gene mutations identifies multiple inter-variant recombination events
Junxian Ou, Wendong Lan, Xiaowei Wu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 187

Temporal maturation of neutralizing antibodies in COVID-19 convalescent individuals improves potency and breadth to circulating SARS-CoV-2 variants
Saya Moriyama, Yu Adachi, Takashi Sato, et al.
Immunity (2021) Vol. 54, Iss. 8, pp. 1841-1852.e4
Open Access | Times Cited: 138

The origins and molecular evolution of SARS-CoV-2 lineage B.1.1.7 in the UK
Verity Hill, Louis du Plessis, Thomas P. Peacock, et al.
Virus Evolution (2022) Vol. 8, Iss. 2
Open Access | Times Cited: 127

Neutralization of SARS-CoV-2 Omicron variant by sera from BNT162b2 or Coronavac vaccine recipients
Lu Lu, Bobo Wing-Yee Mok, Lin‐Lei Chen, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 123

Concerns about SARS-CoV-2 evolution should not hold back efforts to expand vaccination
Sarah Cobey, Daniel B. Larremore, Yonatan H. Grad, et al.
Nature reviews. Immunology (2021) Vol. 21, Iss. 5, pp. 330-335
Open Access | Times Cited: 122

Structural and antigenic variations in the spike protein of emerging SARS-CoV-2 variants
Anshumali Mittal, Arun Khattri, Vikash Verma
PLoS Pathogens (2022) Vol. 18, Iss. 2, pp. e1010260-e1010260
Open Access | Times Cited: 115

Delta Variants of SARS-CoV-2 Cause Significantly Increased Vaccine Breakthrough COVID-19 Cases in Houston, Texas
Paul A. Christensen, Randall J. Olsen, Sheng Long, et al.
American Journal Of Pathology (2021) Vol. 192, Iss. 2, pp. 320-331
Open Access | Times Cited: 110

Recurrent SARS-CoV-2 mutations in immunodeficient patients
Samuel Wilkinson, Alex Richter, Anna Casey, et al.
Virus Evolution (2022) Vol. 8, Iss. 2
Open Access | Times Cited: 103

Deciphering the language of antibodies using self-supervised learning
Jinwoo Leem, L. Mitchell, James H. R. Farmery, et al.
Patterns (2022) Vol. 3, Iss. 7, pp. 100513-100513
Open Access | Times Cited: 97

Cumulative SARS-CoV-2 mutations and corresponding changes in immunity in an immunocompromised patient indicate viral evolution within the host
Sissy Therese Sonnleitner, Martina Prelog, Stefanie Sonnleitner, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 94

A large-scale systematic survey reveals recurring molecular features of public antibody responses to SARS-CoV-2
Yiquan Wang, Meng Yuan, Huibin Lv, et al.
Immunity (2022) Vol. 55, Iss. 6, pp. 1105-1117.e4
Open Access | Times Cited: 85

Structural basis for continued antibody evasion by the SARS-CoV-2 receptor binding domain
Katherine Nabel Smith, Sarah A. Clark, Sundaresh Shankar, et al.
Science (2022) Vol. 375, Iss. 6578
Open Access | Times Cited: 75

SARS-CoV-2 Variants of Concern and Variants of Interest Receptor Binding Domain Mutations and Virus Infectivity
Haolin Liu, Pengcheng Wei, John W. Kappler, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 70

Germline-encoded amino acid–binding motifs drive immunodominant public antibody responses
Ellen Shrock, Richard T. Timms, Tomasz Kula, et al.
Science (2023) Vol. 380, Iss. 6640
Open Access | Times Cited: 55

Page 1 - Next Page

Scroll to top